|
|
|
TEVA Forecast
Recent TEVA Price |
|
TEVA Forecast Price |
$14.08 |
+6.53% |
$15.00 |
As of 2024-05-03
Recent TEVA Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
6 |
6 |
6 |
5 |
Buy ratings: |
0 |
0 |
0 |
0 |
Hold ratings: |
3 |
3 |
2 |
3 |
Sell ratings: |
0 |
0 |
0 |
0 |
Strong sell ratings: |
0 |
0 |
1 |
1 |
Average rating: |
1.67 |
1.67 |
1.89 |
2.11 |
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
For the Teva Pharmaceutical Industries Ltd forecast (traded under symbol TEVA) for one year forward price target at the top of this page, we have presented the average TEVA forecast for forward target price across the 8 analysts covering TEVA, as reported in
data provided by Zacks Investment Research via Quandl.com.
Meanwhile, note that the
median TEVA forecast price target (median being the middle where half of analysts had a higher TEVA forecast and half had a lower TEVA forecast, which is a different metric than the average or mean) was $15.0 as of 2024-05-03, while the
highest TEVA forecast in the analyst group was $19.0, and the lowest TEVA forecast in the analyst group was
$11.0, with a standard deviation of $2.672. Get the latest Zacks research report on TEVA — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Name: |
Teva Pharmaceutical Industries Ltd |
Website: |
www.tevapharm.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding TEVA: |
28 (see which ones) |
Total Market Value Held by ETFs: |
$303,212,712 |
Total Market Capitalization: |
$9,734,000,000 |
% of Market Cap. Held by ETFs: |
3.11% |
|
|
|
|
Quotes delayed 20 minutes
|
Buy (3.33 out of 4)
50th percentile
|
|
|